Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.40 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

protea biosciences group inc (PRGB) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/22/14 - $2.10
52 Week Low
12/17/14 - $0.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

protea biosciences group inc (PRGB) Related Businessweek News

No Related Businessweek News Found

protea biosciences group inc (PRGB) Details

Protea Biosciences Group, Inc., molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The company provides molecular information services for the identification of small and large molecules; and tissue analytics services to create tissue-based molecular profiles. It also offers laser ablation electrospray ionization, a bioanalytical instrument platform that enables the identification of proteins, lipids, and metabolites in tissue, cells, and biofluids, such as serum and urine with minimal or without any sample preparation prior to analysis. It primarily serves pharmaceutical and academic/clinical research laboratories; and pharmaceutical, biotechnology, chemical, and medical device companies through field sales, distributors, in-house sales support, and Web-based marketing. The company was founded in 2001 and is based in Morgantown, West Virginia.

39 Employees
Last Reported Date: 05/1/15
Founded in 2001

protea biosciences group inc (PRGB) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $240.0K
Chief Financial Officer
Total Annual Compensation: $145.6K
Vice President of Operations
Total Annual Compensation: $210.0K
Chief Science Officer and Vice President of R...
Total Annual Compensation: $153.9K
Vice President of Corporate Finance and Devel...
Total Annual Compensation: $131.0K
Compensation as of Fiscal Year 2014.

protea biosciences group inc (PRGB) Key Developments

Protea Biosciences Group, Inc Announces Board Appointments

Effective April 17, 2015, Maged Shenouda and Patrick Gallagher were appointed by the board of directors of Protea Biosciences Group Inc. to serve as directors to fill existing vacancies on the Board. Maged Shenouda has over 25 years of experience in the pharmaceutical and securities industries. Most recently, Mr. Shenouda was the Head of Business Development and Licensing at Retrophin Inc. Patrick Gallagher, CFA, is an accomplished Capital Markets executive, advisor and investor with a distinguished record of success in both the public and private markets with a focus on healthcare, agriculture and industrials. He is a Managing Director and Head of Institutional Sales for Laidlaw & Company (UK) Ltd. Mr. Gallagher sits on the board of directors for BioSig Technologies Inc.

Protea Biosciences Group, Inc. Announces Board Resignations

On March 25, 2015, Andrew Zulauf resigned as a Director of Protea Biosciences Group Inc. On March 31, 2015, Roderick Jackson resigned as a Director of the company.

Protea Biosciences Group, Inc Auditor Raises 'Going Concern' Doubt

Protea Biosciences Group, Inc filed its 10-K on Feb 13, 2015 for the period ending Dec 31, 2014. In this report its auditor, Schneider Downs & Co., Inc., gave an unqualified opinion expressing doubt that the company can continue as a going concern.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRGB:US $0.40 USD 0.00

PRGB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRGB.
View Industry Companies

Industry Analysis


Industry Average

Valuation PRGB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 22.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 21.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROTEA BIOSCIENCES GROUP INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at